Moloney Securities Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-835,250
Closed -$409K 463
2023
Q2
$409K Buy
835,250
+594,350
+247% +$486K 0.07% 266
2023
Q1
$279K Buy
240,900
+99,100
+70% +$181K 0.05% 329
2022
Q4
$380K Buy
141,800
+108,000
+320% +$285K 0.08% 256
2022
Q3
$97K Sell
33,800
-33,739
-50% -$143K 0.02% 352
2022
Q2
$336K Buy
67,539
+20,739
+44% +$109K 0.08% 248
2022
Q1
$333K Buy
46,800
+8,545
+22% +$70.7K 0.06% 276
2021
Q4
$695K Buy
+38,255
New +$826K 0.12% 200

Other funds holding CELL

Moloney Securities Asset Management's CELL Position: Q3 2023 in Review

Moloney Securities Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 835,250 shares — an estimated $409K sold.

Moloney Securities Asset Management first reported a position in CELL in Q4 2021 and held it in 7 quarters. The position peaked at $695K in Q4 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Moloney Securities Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Moloney Securities Asset Management sold 835,250 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $409K.
  • Moloney Securities Asset Management first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Moloney Securities Asset Management's PhenomeX Inc. Common Stock position peaked at $695K in Q4 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Moloney Securities Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.